Latest News and Press Releases

San Diego, CA, April 01, 2020 (GLOBE NEWSWIRE) -- On April 1, 2020, company veteran and Vice President of Sales, Matt Sargent, was promoted to the position of Chief Commercial Officer.  In this...

San Diego, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- A pivotal clinical study validating Breast Cancer Index earns the distinction of being selected for the cover of the Annals of Oncology.  The...

San Diego, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for...

San Diego, CA, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announced today that several abstracts featuring updates on ongoing research and new data examining the Breast Cancer Index®...

San Diego, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- SAN DIEGO, Calif., September 5, 2019 – Biotheranostics, Inc. today announced new pivotal data on the Breast Cancer Index® (BCI) published in the...

San Diego, CA, July 01, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces F. Anthony Greco, MD as Medical Advisor for its CancerTYPE ID® test. CancerTYPE ID helps with identification of...

San Diego, CA, June 03, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announces new pivotal data on the Breast Cancer Index® (BCI) being presented at the ASCO conference June 3, 2019 that further...

San Diego, CA, May 21, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., today announced that Lee Newcomer, M.D., has been elected to its Board of Directors. Dr. Newcomer brings more than 30 years of...

San Diego, California, April 16, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc. announces expanded Medicare coverage for its Breast Cancer Index® test under a new Local Coverage Determination [(LCD)...

San Diego, CA, March 05, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces its Breast Cancer Index (BCI) test has been issued a new Medicare Local Coverage Determination [(LCD) L37822] by...